Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study.
Hendricks LAJ, Verbeek KCJ, Schuurs-Hoeijmakers JHM, de Putter R, Brems H, Van Daele SH, Anastasiadou VC, Foretová L, Benusiglio PR, Gerasimenko A, Colas C, Villy MC, Houdayer C, Branchaud M, Hüneburg R, Aretz S, Jahn A, Steinke-Lange V, Innella G, Turchetti D, Barili V, Genuardi M, Panfili A, Baldassarri M, Irmejs A, de Jong MM, Links TP, Leter EM, Bosch DGM, Donze SH, van der Post RS, Mensenkamp AR, Westdorp H, Høberg-Vetti H, Tveit Haavind M, Jørgensen K, Mæhle L, Briskemyr S, Garcia JD, Blatnik A, Balmaña J, Torres M, Brunet J, Lleuger-Pujol R, Tham E, Tischkowitz M, Evans DG, Hyder Z, Hoogerbrugge N, Vos JR. Hendricks LAJ, et al. Among authors: van der post rs. BJC Rep. 2025 Jun 4;3(1):42. doi: 10.1038/s44276-025-00157-y. BJC Rep. 2025. PMID: 40468016 Free PMC article.
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS).
Hendricks LAJ, Verbeek KCJ, Schuurs-Hoeijmakers JHM, de Jong MM, Links TP, Brems H, Aerden M, Brunet J, Lleuger-Pujol R, Hüneburg R, Aretz S, Colas C, Villy MC, Woodward ER, Evans DG, Bosch DGM, Donze SH, Foretová L, Blatnik A, Leter EM, Tischkowitz M, Jahn A, de Putter R, Dupont J, Briskemyr S, Steinke-Lange V, Baldassarri M, Anastasiadou VC, Irmejs A, Oliveira C, van der Post RS, Mensenkamp AR, Tesi B, Mu N, Benusiglio PR, Gerasimenko A, Innella G, Turchetti D, Houdayer C, Branchaud M, Høberg-Vetti H, Haavind MT, Balmaña J, Torres M, Genuardi M, Panfili A, Jørgensen K, Mæhle L, Hoogerbrugge N, Vos JR. Hendricks LAJ, et al. Among authors: van der post rs. Genet Med. 2025 May 24:101467. doi: 10.1016/j.gim.2025.101467. Online ahead of print. Genet Med. 2025. PMID: 40433764 Free article.
Feasibility and clinical potential of exercise interventions during neoadjuvant chemoradiotherapy in patients with esophageal and rectal cancer.
Mast IH, Gootjes EC, Rütten H, den Hartogh MD, Brouwer CG, Nagtegaal ID, van der Post RS, Hopman MTE, Heuvel BVD, Rosman C, de Wilt JHW, Klarenbeek BR, Buffart LM. Mast IH, et al. Among authors: van der post rs. J Sport Health Sci. 2025 May 24:101060. doi: 10.1016/j.jshs.2025.101060. Online ahead of print. J Sport Health Sci. 2025. PMID: 40419137 Free article.
The DRAGON benchmark for clinical NLP.
Bosma JS, Dercksen K, Builtjes L, André R, Roest C, Fransen SJ, Noordman CR, Navarro-Padilla M, Lefkes J, Alves N, de Grauw MJJ, van Eekelen L, Spronck JMA, Schuurmans M, de Wilde B, Hendrix W, Aswolinskiy W, Saha A, Twilt JJ, Geijs D, Veltman J, Yakar D, de Rooij M, Ciompi F, Hering A, Geerdink J, Huisman H; DRAGON consortium. Bosma JS, et al. NPJ Digit Med. 2025 May 17;8(1):289. doi: 10.1038/s41746-025-01626-x. NPJ Digit Med. 2025. PMID: 40379835 Free PMC article.
Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with constitutional mismatch repair deficiency.
Weijers DD, Hinić S, Kroeze E, Gorris MA, Schreibelt G, Middelkamp S, Mensenkamp AR, Bladergroen R, Verrijp K, Hoogerbrugge N, Wesseling P, van der Post RS, Loeffen JL, Gidding CE, van Kouwen MC, de Vries IJM, van Boxtel R, de Voer RM, Jongmans MC, Kuiper RP. Weijers DD, et al. Among authors: van der post rs. Nat Commun. 2025 May 14;16(1):4459. doi: 10.1038/s41467-025-59775-2. Nat Commun. 2025. PMID: 40368937 Free PMC article.
Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity.
Peeters E, van Genugten EAJ, Heskamp S, de Vries IJM, van Herpen C, Koenen HJPM, Kneilling M, van der Post RS, van Dop WA, Westdorp H, Aarntzen E. Peeters E, et al. Among authors: van der post rs. J Immunother Cancer. 2025 May 7;13(5):e011009. doi: 10.1136/jitc-2024-011009. J Immunother Cancer. 2025. PMID: 40341021 Free PMC article. Review.
Tumour-intrinsic alterations and stromal matrix remodelling promote Wnt-niche independence during diffuse-type gastric cancer progression.
Kemp LJS, Monster JL, Wood CS, Moers M, Vliem MJ, Khalil AA, Jamieson NB, Brosens LAA, Kodach LL, van Dieren JM, Bisseling TM, van der Post RS, Gloerich M. Kemp LJS, et al. Among authors: van der post rs. Gut. 2025 Apr 1:gutjnl-2024-334589. doi: 10.1136/gutjnl-2024-334589. Online ahead of print. Gut. 2025. PMID: 40169243 Free article.
Exome-based cancer predisposition gene testing can provide a genetic diagnosis for individuals with heterogeneous tumor phenotypes.
Hinić S, Mensenkamp AR, Schuurs-Hoeijmakers JHM, Brugnoletti F, Vreede L, van Veen EM, Mijzen B, van der Post RS, Genuardi M, Ligtenberg MJL, Hoogerbrugge N, de Voer RM. Hinić S, et al. Among authors: van der post rs. Eur J Hum Genet. 2025 Jun;33(6):803-809. doi: 10.1038/s41431-025-01814-z. Epub 2025 Feb 20. Eur J Hum Genet. 2025. PMID: 39979679 Free PMC article.
Is it time to acknowledge intramucosal colorectal carcinoma?
Vink-Börger E, Knijn N, de Bruine A, Stavast J, van der Post RS, Nagtegaal I. Vink-Börger E, et al. Among authors: van der post rs. Histopathology. 2025 Apr;86(5):805-812. doi: 10.1111/his.15389. Epub 2024 Dec 9. Histopathology. 2025. PMID: 39648952 Free PMC article.
107 results